Ocwen And Gilead Are Big Market Movers

NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE Ocwen Financial Corp., down $5.89 to $16.01 The subprime mortgage servicer's executive chairman will resign in a settlement that also provides $150 million to homeowners. Nabors Industries Ltd., down 53 cents to $13.10 The oil drilling services company's stock fell as the price of oil continued its monthslong decline on prolonged weak demand. Nasdaq Enanta Pharmaceuticals Inc., up $4.70 to $51.32 The biotechnology company's development partner AbbVie Inc.Read more on NewsOK.com

Sections:  news   business   
BING NEWS:
  • Gilead's Trodelvy Fails To Hit Primary Goal In Late-Stage Study With Most Common Type Of Bladder Cancer
    In the overall study population, there was a higher number of deaths due to adverse events with Trodelvy compared to TPC. Gilead continues to analyze the data and will discuss the results and next ...
    05/31/2024 - 12:59 pm | View Link
  • Gilead drug fails to confirm its FDA approval in bladder cancer
    A Gilead drug has been approved for breast cancer, but the FDA could remove its approval in bladder cancer. It failed a late-stage trial earlier this year in a type of lung cancer.
    05/31/2024 - 10:55 am | View Link
  • Hold Rating on Gilead Sciences Amid Trodelvy Trial Setbacks and Future Uncertainties
    with bladder cancer sales contributing less than 10% to Trodelvy’s current revenue and anticipated to account for less than 1% of Gilead’s total revenue by 2030. Despite this, the broader implications ...
    05/30/2024 - 4:46 pm | View Link
  • Gilead : Phase 3 Study Of Trodelvy In Metastatic Urothelial Cancer Fails To Meet Primary Endpoint
    Gilead Sciences Inc. (GILD) said that the confirmatory Phase 3 TROPiCS-04 study of Trodelvy in locally advanced or metastatic ...
    05/30/2024 - 4:14 pm | View Link
  • Gilead's Trodelvy fails to meet main goal in late-stage cancer study
    Gilead Sciences said on Thursday its drug Trodelvy, tested in patients with bladder cancer who previously received chemotherapy, did not meet the main goal of a late-stage study.
    05/30/2024 - 9:43 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News